questions17 Nov 2020 13:28
10th july trading update sp 83p,
final results 17th nov sp approx. 52p
no covid -related sales in H1 or H2 to justify the current SP, not even in areas where approval has already been given and where sales were expected (remember the 1 million pending approval from trading update 10th of july)?
GDR must feel like the ugly duckling so why is the product so unwanted at the start and middle of a pandemic?
The competitors are plainly better than gdr
Europe is in the middle of the second wave now, why hasn't the "european country" ordered now? why wait until Q1 2021? This is a health and economic emergency, after all.
My conclusion: GDR are peddling an unwanted product. They tried to jump on the covid-testing bandwagon had failed terribly so far. The only chance is the POC . I suspect its POC test that the european country is interested in and that still needs testing and approvals. In the meantime, positive vaccine announce will continue and vaccinations will start (thankfully!).